Provided by Tiger Fintech (Singapore) Pte. Ltd.

Charles River Laboratories

168.11
-7.0150-4.01%
Volume:532.98K
Turnover:90.29M
Market Cap:8.60B
PE:840.52
High:175.07
Open:174.50
Low:165.67
Close:175.12
Loading ...

FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs

Benzinga
·
22 Jan

FDA Approves Johnson & Johnson's Treatment As First Monotherapy For Treatment-Resistant Depression

Benzinga
·
22 Jan

TD Cowen Adjusts Charles River Laboratories International Price Target to $182 From $227

MT Newswires Live
·
21 Jan

RiverWater Partners Sustainable Value Strategy Sold Evercore (EVR) on Share Appreciation

Insider Monkey
·
21 Jan

What Makes Charles River Labs (CRL) an Investment Bet?

Insider Monkey
·
21 Jan

Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences

Business Wire
·
21 Jan

Atara Biotherapeutics Provides Update on Clinical Programs Related to EBVALLO™ (tabelecleucel) and ATA3219

Business Wire
·
21 Jan

Charles River Laboratories Mid-term Sales Growth Structurally Slowed Down, UBS Says

MT Newswires Live
·
18 Jan

UBS Downgrades Charles River Laboratories International to Neutral From Buy, Adjusts Price Target to $185 From $250

MT Newswires Live
·
17 Jan

ATRA Stock Down After FDA Issues CRL for Rare Blood Cancer Candidate

Zacks
·
17 Jan

Charles River Labs Cut to Neutral From Buy by UBS

Dow Jones
·
17 Jan

Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?

Zacks
·
17 Jan

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EST

Reuters
·
17 Jan

Charles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms

MT Newswires Live
·
17 Jan

Charles River and Akron Bio Announce Collaboration to Enhance Operations With Integration of Cgmp Materials Into Cell Therapy Platform

THOMSON REUTERS
·
16 Jan

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform

Business Wire
·
16 Jan